
Sign up to save your podcasts
Or


The SPRINT study, suggesting that we aim for a systolic BP target of 120 mm Hg in high-risk hypertensive patients, has been published with much fanfare.
Dr. Paul Whelton — one of the SPRINT investigators — is our guest. He warns against setting 120 as a performance measure, observing that roughly half the patients in the aggressively treated group had levels above that.
Links:
NEJM article (free)
By NEJM Group4.5
5656 ratings
The SPRINT study, suggesting that we aim for a systolic BP target of 120 mm Hg in high-risk hypertensive patients, has been published with much fanfare.
Dr. Paul Whelton — one of the SPRINT investigators — is our guest. He warns against setting 120 as a performance measure, observing that roughly half the patients in the aggressively treated group had levels above that.
Links:
NEJM article (free)

7,870 Listeners

319 Listeners

2,050 Listeners

124 Listeners

502 Listeners

298 Listeners

903 Listeners

266 Listeners

3,387 Listeners

113,515 Listeners

89 Listeners

5 Listeners

90 Listeners

521 Listeners

2,577 Listeners

367 Listeners

16,576 Listeners

58 Listeners

31 Listeners

67 Listeners